论文部分内容阅读
这篇文章主要是为了讨论肿瘤患者内科的抗感染药物情况。我们可以选取2014年到2015年年间某县的资料。肿瘤资料的患者人数在一百例左右。运用的资料主要包括患者的病历、治疗方案和用药名称、药物使用的频率和总共治疗的费用等等。结果表明,在所有的患者中,治疗性用药的患者比例达到了70%左右,预防性用药的比例在15%左右,在病人没有指征的情况下用药达到了7%左右。根据相关专业人员的统计,其中头孢类药物用的是最多的,占到了一半以上,因此患者的主要治疗费用也主要花费在头孢类的抗菌药物上。
This article is mainly intended to discuss the anti-infectives of internal medicine in cancer patients. We can select the data of a county from 2014 to 2015. The number of patients with tumor information in about 100 cases. The information used mainly includes the patient’s medical history, treatment plan and medication name, the frequency of drug use and the total cost of treatment and so on. The results showed that in all patients, the proportion of patients treated with therapeutic drugs reached about 70%, the proportion of prophylactic medication was about 15%, medication reached about 7% in patients without indications. According to statistics of relevant professionals, among them, cephalosporins are the most used, accounting for more than half, so the patient’s main treatment costs are mainly spent on antibacterial drugs cephalosporins.